久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Trials with Oxford COVID-19 vaccine start in Brazil

expresspharmaJune 24, 2020

Tag: brazil , COVID-19 , Oxford vaccine

Oxford University in this weekend started human clinical trials for a potential coronavirus vaccine in Brazil, sponsor Lemann Foundation said in a statement.

Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro.

Brazil’s health regulator Anvisa approved human clinical trials for this potential vaccine, developed by Oxford and supported by AstraZeneca, earlier in June.

Brazil, where the disease is still rife, is the first country outside the United Kingdom to start testing the Oxford vaccine.

Researchers expect to launch the vaccine by year-end.


Previous:Inovio gets $71 million from US defense department for COVID-19 vaccine device

Next:Powder Flow: Optimising Unit Operations using the FT4 Powder Rheometer?

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service